CompletedPhase 2NCT00097773
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seattle Children's Hospital
- Principal Investigator
- Bonnie W. Ramsey, M.DUniversity of Washington
- Intervention
- Tobramycin solution for inhalation (TOBI)(drug)
- Enrollment
- 304 enrolled
- Eligibility
- 1-12 years · All sexes
- Timeline
- 2004 – 2009
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Northern California Kaiser Cystic Fibrosis Center, Oakland, California, United States
- Stanford University, Palo Alto, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Children's Hospital Denver, Aurora, Colorado, United States
- duPont Hospital for Children, Wilmington, Delaware, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- All Children's Hospital Cystic Fibrosis Center, St. Petersburg, Florida, United States
- Emory University Cystic Fibrosis Center, Atlanta, Georgia, United States
- Medical College of Georgia, Augusta, Georgia, United States
- Children's Memorial Hospital, Chicago, Illinois, United States
- Riley Hospital/Indiana University, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kentucky, Lexington, Kentucky, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Heart, Lung, and Blood Institute (NHLBI) · Cystic Fibrosis Foundation · CF Therapeutics Development Network Coordinating Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00097773 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.